Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share

robot
Abstract generation in progress

Wellgistics Health, Inc. announced that its President and Interim CEO, Prashant Patel, along with another board member, has converted approximately $2.0 million in deferred compensation into 10 million shares of the company’s common stock at $0.20 per share, a premium to recent trading prices. This move, which also included the issuance of 10 million warrants, aims to align management incentives with long-term shareholder value and underscores Mr. Patel’s confidence in the company’s strategic direction. The newly issued shares are subject to a 6-month lock-up agreement, further demonstrating commitment to the company’s future in health information technology.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments